Bioxytran, Inc
BIXT· OTC
Filed May 15, 2012 · 10-Q · 45 days after period end · 0001213900-12-002595
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $133.41K | $7.93K |
| Net Income | -$466.92K | -$1.39M |
| EPS Diluted | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 15, 2012 · 45 d after period end